Connectome

META Dynamic Inc. Enters Strategic Partnership with Omniscient Neurotechnology to Distribute Quicktome™ Brain-Mapping Software

Retrieved on: 
Tuesday, April 16, 2024
Eclipse, Language, OSS, Connectome, Map, AI, Omniscience, Software suite, Business development, Partnership, Neurosurgery, MSSI, Movement, MRI

Designed by neurosurgeons and data scientists, the Quicktome™ Software Suite is a cloud-based connectomic analysis platform that allows neurosurgeons to visualize and understand a patient’s brain networks prior to performing life-changing neurosurgery.

Key Points: 
  • Designed by neurosurgeons and data scientists, the Quicktome™ Software Suite is a cloud-based connectomic analysis platform that allows neurosurgeons to visualize and understand a patient’s brain networks prior to performing life-changing neurosurgery.
  • These brain networks are responsible for everything from language to movement to thought, and when impacted, can cause costly complications for the patient and hospital alike.
  • Quicktome is the only commercially available platform that can automatically map a patient’s unique connectome, informing surgical decision making.
  • These offerings enhance operating room efficiency and productivity and are now bolstered with Quicktome™ software.

Soterix Medical Announces award of Fast Track NIH grant to develop a Parcel-Guided software to improve efficacy of rTMS treatment for Depression

Retrieved on: 
Thursday, October 13, 2022
National Institute, Connectome, Depression (mood), TMS, National Institute of Mental Health, NIMH, Patient, Depression, Transcranial magnetic stimulation, Technology, Software, Columbia University, SMI, Human Connectome Project, Neuronavigation, Fast Track, HCP, Mental health, FDA, Principal, Pharmaceutical industry

The award implements a personalized parcel-guided repetitive Transcranial Magnetic Stimulation (rTMS) approach through cloud-based targeting software and validates performance in clinical trials in patients with treatment resistant depression at Columbia University.

Key Points: 
  • The award implements a personalized parcel-guided repetitive Transcranial Magnetic Stimulation (rTMS) approach through cloud-based targeting software and validates performance in clinical trials in patients with treatment resistant depression at Columbia University.
  • Soterix Medical's award is for $910,000 over two years, expandable by an additional $1.4 million for follow-on pivotal clinical trials.
  • Our ultimate goal is to develop an FDA approved targeting algorithm for standard TMS-resistant Treatment resistant Depression."
  • Soterix Medical already holds FDA clearance for Neuronavigation that is intended for the accurate positioning of treatment coil during rTMS.

Omniscient Neurotechnology Launches Quicktome™ Brain Mapping Platform for Neurosurgery After Regulatory Clearance in United States, Canada and Australia

Retrieved on: 
Wednesday, July 21, 2021
FDA, Other Health, Technology, Pharmaceutical, Practice Management, Oncology, General Health, Hospitals, Other Technology, Science, Biotechnology, Networks, Other Science, Health, Research, Branches of biology, Neuroscience, Medical specialties, Computational neuroscience, Cognitive neuroscience, Neuroimaging, Neurosurgery, Connectome, Neurotechnology, Brain mapping, Omniscient Neurotechnology, Quicktome™, OMNISCIENT NEUROTECHNOLOGY, QUICKTOME™

(Photo: Business Wire)

Key Points: 
  • (Photo: Business Wire)
    In addition to FDA clearance in the United States, Quicktome has also received Health Canada approval as well as regulatory clearance by the Therapeutic Goods Administration (TGA) of Australia.
  • This is the first digital mapping platform designed to incorporate brain connectome data for neurosurgeons to improve patient outcomes, said Stephen Scheeler, CEO, Omniscient Neurotechnology.
  • Quicktome is a digital brain mapping platform that allows neurosurgeons to visualize and understand a patient's brain networks prior to performing life-changing brain surgery.
  • Quicktome recently received regulatory clearance in the United States, Canada, and Australia.

Biomax Informatics : Universities use NeuroXM™ to study the connectome in drug-resistant epilepsy

Retrieved on: 
Thursday, May 20, 2021
Software, Research, Data management, Medical devices, Technology, Hospitals, University, Education, Science, Surgery, Biotechnology, Health, Computational neuroscience, Branches of biology, Neuroscience, Cognitive neuroscience, Emerging technologies, Academic disciplines, Biomax, Bioinformatics, Connectome, Neuroinformatics, Neuroimaging, Conn, the NeuroXM Brain Science Suite, Biomax Informatics, THE NEUROXM BRAIN SCIENCE SUITE, BIOMAX INFORMATICS

b'Using Biomax Informatics\' NeuroXM knowledge management platform, scientists from the Universities of Nottingham, Newcastle, Qingdao, Shanghai and Munich have studied the change in the connectome in drug-resistant epilepsy patients.

Key Points: 
  • b'Using Biomax Informatics\' NeuroXM knowledge management platform, scientists from the Universities of Nottingham, Newcastle, Qingdao, Shanghai and Munich have studied the change in the connectome in drug-resistant epilepsy patients.
  • This connectivity network could then be visualized and accessed via the web portal of NICARA\xe2\x84\xa2, the neuroimaging solution offered by Biomax.
  • "Our experience shows us that our software can be easily deployed in hospitals," explained project leader Dr. Markus Butz-Ostendorf of Biomax.
  • Marcus Kaiser, Professor of Neuroinformatics at the University of Nottingham, confirms, "The use of NeuroXM and NICARA is central to this research project.

Excess Weight Among Pregnant Women May Interfere With Child's Developing Brain

Retrieved on: 
Tuesday, August 11, 2020
Branches of biology, Anatomy, Neuroscience, Cognitive neuroscience, Neuroimaging, Animal anatomy, Brain, Organs, Electroencephalography, Connectome, Functional magnetic resonance imaging

Using millions of computations, the study authors divided the groups into 16 meaningful subgroups based on over 19,000 possible connections between the groups of neurons.

Key Points: 
  • Using millions of computations, the study authors divided the groups into 16 meaningful subgroups based on over 19,000 possible connections between the groups of neurons.
  • They found only two areas of the brain where their connections to each other were statistically strongly linked to the mother's BMI.
  • Previous studies showing an association between obesity and brain development had mostly looked at cognitive function in children after birth.
  • The research team used MRI imaging to measure fetal brain activity and map patterns of communication between large numbers of brain cells clustered together in different regions of the brain.

Imaging Reveals Pathways Behind Depression

Retrieved on: 
Tuesday, December 3, 2019
Depression, Psychiatric diagnosis, Neuroscience, Psychiatry, RTT, Neuropsychology, Psychology, Abnormal psychology, Connectome, Major depressive disorder, Differential diagnoses of depression

"To develop new, more effective treatments, we must improve our understanding of the disorder."

Key Points: 
  • "To develop new, more effective treatments, we must improve our understanding of the disorder."
  • "This study helps improve our understanding of the pathophysiology of depression and can open new avenues of treatment for a disorder that affects over 100 million individuals worldwide."
  • A second study presented at RSNA 2019 looked at abnormalities in the complex network of connections in the brain known as the connectome for their role in depression.
  • Dr. Li said the new approach could open the door for a deeper understanding of the mechanisms behind depression.

A Revolution in Marketing: TriggersⓇ and Wharton Prof Announce the Brand ConnectomeⓇ

Retrieved on: 
Monday, January 14, 2019
Market economics), Marketing, Microeconomics, Product management, Brand management, Brand, Emotional branding, Connectome

At the core of this discovery is the Brand Connectome, a mini-network of associations composed of every memory a customer has of the brand.

Key Points: 
  • At the core of this discovery is the Brand Connectome, a mini-network of associations composed of every memory a customer has of the brand.
  • "Now, we have found that what lies within this shortcut is a dynamic network of associations and memories," they write.
  • Triggers , formerly known as the Center for Emotional Marketing, is the leading brand strategy and innovation firm for driving accelerated growth.
  • Leslie Zane created Triggers 24 years ago after she found traditional brand management to be resistant, at that time, to her innovative ideas about autonomic decision-making.